ArticleFrontiers in oncology2021

A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.